Highlights from ASCO 2025 in early-stage NSCLC include updates on CheckMate 816 on neoadjuvant nivolumab, NeoADAURA on osimertinib, and data on low-dose CT screening, presented by Dr Jonathan Goldman.

The National Weather Service on Friday upgraded its fire weather watch to a red flag warning for most of Northern and Central ...

New Delhi, June 17, 2025 - As the global Web3 ecosystem transitions from speculative excitement to sustainable innovation, ...